Concepts (251)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 6 | 2020 | 179 | 1.340 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2020 | 1437 | 0.860 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 390 | 0.780 |
Why?
|
| Hypoglycemic Agents | 8 | 2017 | 186 | 0.690 |
Why?
|
| Risk Assessment | 8 | 2020 | 1425 | 0.660 |
Why?
|
| Chest Pain | 5 | 2020 | 205 | 0.660 |
Why?
|
| Psoas Muscles | 1 | 2019 | 16 | 0.600 |
Why?
|
| Mass Screening | 2 | 2020 | 256 | 0.580 |
Why?
|
| Sarcopenia | 1 | 2019 | 50 | 0.580 |
Why?
|
| Aged | 31 | 2020 | 10260 | 0.540 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 907 | 0.510 |
Why?
|
| Male | 39 | 2020 | 19437 | 0.510 |
Why?
|
| United States | 16 | 2020 | 4072 | 0.480 |
Why?
|
| Female | 36 | 2020 | 19942 | 0.470 |
Why?
|
| Humans | 48 | 2020 | 32274 | 0.460 |
Why?
|
| Middle Aged | 31 | 2020 | 11848 | 0.440 |
Why?
|
| Adult | 23 | 2020 | 9256 | 0.440 |
Why?
|
| Proportional Hazards Models | 10 | 2019 | 773 | 0.420 |
Why?
|
| Models, Statistical | 3 | 2014 | 187 | 0.420 |
Why?
|
| Predictive Value of Tests | 5 | 2020 | 883 | 0.410 |
Why?
|
| Online Systems | 1 | 2014 | 11 | 0.410 |
Why?
|
| Acute Coronary Syndrome | 3 | 2020 | 167 | 0.400 |
Why?
|
| Forecasting | 1 | 2014 | 144 | 0.400 |
Why?
|
| Diabetic Angiopathies | 3 | 2017 | 150 | 0.390 |
Why?
|
| Mortality | 3 | 2020 | 122 | 0.380 |
Why?
|
| Patient Readmission | 3 | 2019 | 135 | 0.380 |
Why?
|
| Cardiovascular Diseases | 3 | 2005 | 1158 | 0.380 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 219 | 0.350 |
Why?
|
| Cohort Studies | 8 | 2019 | 1840 | 0.340 |
Why?
|
| Point-of-Care Systems | 2 | 2017 | 44 | 0.320 |
Why?
|
| Hospitalization | 4 | 2020 | 475 | 0.320 |
Why?
|
| Neoplasms | 5 | 2013 | 754 | 0.320 |
Why?
|
| Risk Factors | 17 | 2019 | 3934 | 0.310 |
Why?
|
| Cholesterol | 3 | 2005 | 262 | 0.310 |
Why?
|
| C-Reactive Protein | 3 | 2005 | 227 | 0.300 |
Why?
|
| Health Care Costs | 1 | 2009 | 122 | 0.280 |
Why?
|
| Iron | 2 | 2005 | 94 | 0.280 |
Why?
|
| Metformin | 4 | 2016 | 25 | 0.280 |
Why?
|
| Myocardial Infarction | 4 | 2020 | 465 | 0.280 |
Why?
|
| Medicare | 2 | 2019 | 219 | 0.270 |
Why?
|
| Transferrin | 2 | 2005 | 26 | 0.270 |
Why?
|
| Delivery of Health Care | 1 | 2009 | 167 | 0.270 |
Why?
|
| Cholesterol, LDL | 2 | 2004 | 170 | 0.250 |
Why?
|
| Medical Records | 2 | 2003 | 75 | 0.240 |
Why?
|
| Patient Discharge | 3 | 2019 | 204 | 0.240 |
Why?
|
| Algorithms | 4 | 2020 | 536 | 0.230 |
Why?
|
| Odds Ratio | 6 | 2020 | 456 | 0.230 |
Why?
|
| Hypothyroidism | 1 | 2005 | 10 | 0.230 |
Why?
|
| Troponin | 3 | 2020 | 101 | 0.220 |
Why?
|
| Arginine | 1 | 2005 | 23 | 0.220 |
Why?
|
| Autoantibodies | 1 | 2005 | 50 | 0.220 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2004 | 2 | 0.220 |
Why?
|
| Chlamydophila Infections | 1 | 2004 | 2 | 0.220 |
Why?
|
| Macrolides | 1 | 2004 | 5 | 0.220 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2005 | 51 | 0.210 |
Why?
|
| Myocardial Ischemia | 1 | 2004 | 98 | 0.200 |
Why?
|
| Dementia | 2 | 2005 | 246 | 0.200 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 37 | 0.200 |
Why?
|
| Nomograms | 3 | 2014 | 35 | 0.200 |
Why?
|
| Resuscitation Orders | 1 | 2003 | 13 | 0.200 |
Why?
|
| Drug Combinations | 1 | 2003 | 101 | 0.190 |
Why?
|
| Young Adult | 5 | 2020 | 2648 | 0.190 |
Why?
|
| Religion and Medicine | 1 | 2003 | 18 | 0.190 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2002 | 10 | 0.190 |
Why?
|
| Physician's Role | 1 | 2003 | 41 | 0.190 |
Why?
|
| Unnecessary Procedures | 1 | 2002 | 16 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2002 | 29 | 0.190 |
Why?
|
| Retrospective Studies | 11 | 2017 | 3624 | 0.190 |
Why?
|
| Time Factors | 5 | 2019 | 2204 | 0.180 |
Why?
|
| Sex Factors | 4 | 2020 | 655 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 324 | 0.180 |
Why?
|
| Comorbidity | 5 | 2017 | 565 | 0.180 |
Why?
|
| Logistic Models | 6 | 2020 | 743 | 0.180 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 489 | 0.180 |
Why?
|
| Prognosis | 4 | 2019 | 1534 | 0.170 |
Why?
|
| Age of Onset | 1 | 2020 | 90 | 0.160 |
Why?
|
| Radiography, Abdominal | 1 | 2019 | 15 | 0.150 |
Why?
|
| Body Mass Index | 2 | 2017 | 863 | 0.150 |
Why?
|
| Holidays | 1 | 2019 | 4 | 0.150 |
Why?
|
| Models, Biological | 2 | 2012 | 408 | 0.150 |
Why?
|
| Eggs | 1 | 2018 | 4 | 0.140 |
Why?
|
| Internal Medicine | 1 | 2019 | 53 | 0.140 |
Why?
|
| Meat | 1 | 2018 | 16 | 0.140 |
Why?
|
| Organ Size | 1 | 2019 | 221 | 0.140 |
Why?
|
| Age Factors | 3 | 2019 | 1179 | 0.140 |
Why?
|
| Survival Analysis | 4 | 2019 | 477 | 0.140 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 267 | 0.140 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3898 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 73 | 0.140 |
Why?
|
| Ethnic Groups | 1 | 2020 | 450 | 0.140 |
Why?
|
| Heart Failure | 3 | 2017 | 728 | 0.140 |
Why?
|
| Glycemic Index | 1 | 2017 | 14 | 0.130 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2019 | 158 | 0.130 |
Why?
|
| Hip Fractures | 1 | 2017 | 26 | 0.130 |
Why?
|
| Feeding Behavior | 1 | 2018 | 154 | 0.130 |
Why?
|
| Pneumonia | 1 | 2017 | 62 | 0.130 |
Why?
|
| Nutrition Surveys | 4 | 2005 | 144 | 0.130 |
Why?
|
| Nutritional Status | 1 | 2017 | 73 | 0.130 |
Why?
|
| Oximetry | 1 | 2016 | 32 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2017 | 171 | 0.120 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 27 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2016 | 40 | 0.120 |
Why?
|
| Diet | 1 | 2018 | 383 | 0.120 |
Why?
|
| Emergency Service, Hospital | 4 | 2020 | 444 | 0.120 |
Why?
|
| Risk | 4 | 2015 | 305 | 0.120 |
Why?
|
| Oxygen | 1 | 2016 | 138 | 0.120 |
Why?
|
| Smoking | 4 | 2009 | 505 | 0.120 |
Why?
|
| Sulfonylurea Compounds | 5 | 2015 | 9 | 0.120 |
Why?
|
| Coronary Artery Disease | 2 | 2017 | 427 | 0.110 |
Why?
|
| Social Class | 1 | 2015 | 90 | 0.110 |
Why?
|
| Adolescent | 2 | 2020 | 3517 | 0.110 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 2 | 2013 | 133 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 97 | 0.110 |
Why?
|
| Decision Support Techniques | 2 | 2020 | 130 | 0.110 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 853 | 0.110 |
Why?
|
| Blood Chemical Analysis | 1 | 2014 | 14 | 0.110 |
Why?
|
| Hematologic Tests | 1 | 2014 | 12 | 0.100 |
Why?
|
| Multiple Sclerosis | 1 | 2015 | 62 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2015 | 180 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2012 | 368 | 0.100 |
Why?
|
| Decision Making | 1 | 2015 | 189 | 0.100 |
Why?
|
| Continental Population Groups | 1 | 2014 | 228 | 0.090 |
Why?
|
| Albuminuria | 1 | 2013 | 172 | 0.090 |
Why?
|
| North Carolina | 3 | 2020 | 1300 | 0.090 |
Why?
|
| Computational Biology | 1 | 2012 | 99 | 0.090 |
Why?
|
| Energy Intake | 2 | 2018 | 122 | 0.090 |
Why?
|
| Stroke | 1 | 2017 | 691 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2011 | 26 | 0.080 |
Why?
|
| Obesity | 1 | 2017 | 1111 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 1223 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 2009 | 14 | 0.080 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 11 | 0.080 |
Why?
|
| Incidence | 3 | 2013 | 1241 | 0.080 |
Why?
|
| Unemployment | 1 | 2009 | 4 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2020 | 2316 | 0.080 |
Why?
|
| Efficiency | 1 | 2009 | 17 | 0.080 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2009 | 21 | 0.080 |
Why?
|
| ROC Curve | 3 | 2017 | 169 | 0.080 |
Why?
|
| Employment | 1 | 2009 | 44 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 72 | 0.070 |
Why?
|
| Health Surveys | 1 | 2009 | 175 | 0.070 |
Why?
|
| Software | 1 | 2009 | 124 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2009 | 64 | 0.070 |
Why?
|
| Surgical Wound Infection | 1 | 2009 | 99 | 0.070 |
Why?
|
| Thiazolidinediones | 3 | 2015 | 46 | 0.070 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2009 | 95 | 0.070 |
Why?
|
| Length of Stay | 1 | 2009 | 321 | 0.070 |
Why?
|
| African Americans | 2 | 2020 | 1335 | 0.070 |
Why?
|
| Academic Medical Centers | 2 | 2019 | 161 | 0.070 |
Why?
|
| Coronary Disease | 1 | 2009 | 226 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2017 | 33 | 0.060 |
Why?
|
| Triglycerides | 2 | 2005 | 235 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2007 | 65 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2019 | 757 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2008 | 854 | 0.060 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 2240 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 167 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2015 | 651 | 0.060 |
Why?
|
| Prevalence | 2 | 2019 | 955 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2013 | 3416 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Thyroglobulin | 1 | 2005 | 2 | 0.060 |
Why?
|
| Thyroid Function Tests | 1 | 2005 | 3 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2005 | 47 | 0.060 |
Why?
|
| Thyrotropin | 1 | 2005 | 7 | 0.060 |
Why?
|
| Thyroxine | 1 | 2005 | 16 | 0.060 |
Why?
|
| Epidemiologic Methods | 1 | 2005 | 22 | 0.060 |
Why?
|
| Dietary Fiber | 1 | 2005 | 20 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2020 | 623 | 0.050 |
Why?
|
| Lipoproteins, LDL | 1 | 2005 | 99 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2005 | 141 | 0.050 |
Why?
|
| Mental Recall | 1 | 2005 | 47 | 0.050 |
Why?
|
| Oxidation-Reduction | 1 | 2005 | 274 | 0.050 |
Why?
|
| Ferritins | 1 | 2004 | 38 | 0.050 |
Why?
|
| Lipids | 1 | 2005 | 253 | 0.050 |
Why?
|
| Cholesterol, HDL | 1 | 2004 | 181 | 0.050 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2003 | 1 | 0.050 |
Why?
|
| Registries | 2 | 2015 | 294 | 0.050 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 250 | 0.050 |
Why?
|
| Nutrition Disorders | 1 | 2002 | 10 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2002 | 8 | 0.050 |
Why?
|
| Gastrostomy | 1 | 2002 | 17 | 0.050 |
Why?
|
| Canada | 1 | 2002 | 63 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2002 | 52 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 541 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2003 | 148 | 0.050 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 280 | 0.040 |
Why?
|
| Glyburide | 2 | 2012 | 3 | 0.040 |
Why?
|
| Glipizide | 2 | 2012 | 3 | 0.040 |
Why?
|
| Exercise | 1 | 2005 | 603 | 0.040 |
Why?
|
| Acute Disease | 1 | 2020 | 253 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2012 | 757 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 556 | 0.040 |
Why?
|
| Diet Surveys | 1 | 2018 | 48 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 502 | 0.040 |
Why?
|
| Accidental Falls | 1 | 2019 | 104 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2017 | 95 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2017 | 51 | 0.030 |
Why?
|
| Quality of Life | 1 | 2002 | 964 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 1076 | 0.030 |
Why?
|
| Partial Pressure | 1 | 2016 | 6 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 2016 | 16 | 0.030 |
Why?
|
| Goals | 1 | 2016 | 34 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2016 | 165 | 0.030 |
Why?
|
| Hyperglycemia | 1 | 2016 | 85 | 0.030 |
Why?
|
| Radiculopathy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2020 | 772 | 0.030 |
Why?
|
| Spinal Cord Diseases | 1 | 2015 | 14 | 0.030 |
Why?
|
| Dipeptidyl-Peptidase IV Inhibitors | 1 | 2015 | 3 | 0.030 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 484 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2015 | 273 | 0.030 |
Why?
|
| Insurance Coverage | 1 | 2015 | 80 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2015 | 53 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 292 | 0.030 |
Why?
|
| Biguanides | 1 | 2013 | 3 | 0.030 |
Why?
|
| Ohio | 1 | 2013 | 63 | 0.030 |
Why?
|
| Benzamides | 1 | 2013 | 60 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 1479 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 893 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2015 | 414 | 0.020 |
Why?
|
| Propensity Score | 1 | 2012 | 47 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2015 | 316 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 160 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 222 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 314 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 90 | 0.020 |
Why?
|
| Hypertension | 1 | 2017 | 979 | 0.020 |
Why?
|
| Child | 1 | 2016 | 2434 | 0.020 |
Why?
|
| Ileostomy | 1 | 2009 | 8 | 0.020 |
Why?
|
| Proctocolectomy, Restorative | 1 | 2009 | 17 | 0.020 |
Why?
|
| Skilled Nursing Facilities | 1 | 2009 | 13 | 0.020 |
Why?
|
| Colectomy | 1 | 2009 | 30 | 0.020 |
Why?
|
| Lymph Node Excision | 1 | 2009 | 94 | 0.020 |
Why?
|
| Disease Progression | 1 | 2011 | 591 | 0.020 |
Why?
|
| Walking | 1 | 2009 | 200 | 0.020 |
Why?
|
| Reoperation | 1 | 2009 | 252 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2009 | 100 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 461 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 381 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2009 | 178 | 0.020 |
Why?
|
| Survivors | 1 | 2009 | 173 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2007 | 13 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2007 | 75 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 490 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 762 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2007 | 553 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2005 | 174 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 194 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 2004 | 29 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 595 | 0.010 |
Why?
|